138 related articles for article (PubMed ID: 32416138)
1. Evaluation of a tandem Chlamydia psittaci Pgp3 multiepitope peptide vaccine against a pulmonary chlamydial challenge in mice.
Wang C; Li Y; Wang S; Yan X; Xiao J; Chen Y; Zheng K; Tan Y; Yu J; Lu C; Wu Y
Microb Pathog; 2020 Oct; 147():104256. PubMed ID: 32416138
[TBL] [Abstract][Full Text] [Related]
2. A recombinant multi-epitope peptide vaccine based on MOMP and CPSIT_p6 protein protects against Chlamydia psittaci lung infection.
Li Y; Zheng K; Tan Y; Wen Y; Wang C; Chen Q; Yu J; Xu M; Tan M; Wu Y
Appl Microbiol Biotechnol; 2019 Jan; 103(2):941-952. PubMed ID: 30467705
[TBL] [Abstract][Full Text] [Related]
3. Protective Immunity against
Wang C; Jin Y; Wang J; Zheng K; Lei A; Lu C; Wang S; Wu Y
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108176
[No Abstract] [Full Text] [Related]
4. Recombinant protein CPSIT_0846 induces protective immunity against Chlamydia psittaci infection in BALB/c mice.
Ran O; Liang M; Yu J; Yu M; Song Y; Yimou W
Pathog Dis; 2017 Apr; 75(3):. PubMed ID: 28204474
[TBL] [Abstract][Full Text] [Related]
5. Protective immunity induced by recombinant protein CPSIT_p8 of Chlamydia psittaci.
Liang M; Wen Y; Ran O; Chen L; Wang C; Li L; Xie Y; Zhang Y; Chen C; Wu Y
Appl Microbiol Biotechnol; 2016 Jul; 100(14):6385-6393. PubMed ID: 27052378
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted
Li Y; Wang C; Sun Z; Xiao J; Yan X; Chen Y; Yu J; Wu Y
Int J Nanomedicine; 2019; 14():8179-8193. PubMed ID: 31632026
[TBL] [Abstract][Full Text] [Related]
7. MOMP and MIP DNA-loaded bacterial ghosts reduce the severity of lung lesions in mice after Chlamydia psittaci respiratory tract infection.
Zhou P; Wu H; Chen S; Bai Q; Chen X; Chen L; Zeng X; Liu L; Chen L
Immunobiology; 2019 Nov; 224(6):739-746. PubMed ID: 31561842
[TBL] [Abstract][Full Text] [Related]
8. Immunization with Chlamydia psittaci plasmid-encoded protein CPSIT_p7 induces partial protective immunity against chlamydia lung infection in mice.
Tan Y; Li Y; Zhang Y; Yu J; Wen Y; Wang C; Xu M; Chen Q; Lu C; Wu Y
Immunol Res; 2018 Aug; 66(4):471-479. PubMed ID: 30097797
[TBL] [Abstract][Full Text] [Related]
9. Whole genome sequencing characteristics of Chlamydia psittaci caprine AMK-16 strain, a promising killed whole cell veterinary vaccine candidate against chlamydia infection.
Feodorova VA; Zaitsev SS; Lyapina AM; Kichemazova NV; Saltykov YV; Khizhnyakova MA; Evstifeev VV; Larionova OS
PLoS One; 2023; 18(10):e0293612. PubMed ID: 37903115
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
11. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue.
Huang J; Wang MD; Lenz S; Gao D; Kaltenboeck B
J Immunol; 1999 Feb; 162(4):2217-26. PubMed ID: 9973497
[TBL] [Abstract][Full Text] [Related]
12. Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.
Li Z; Wang S; Wu Y; Zhong G; Chen D
Sci China C Life Sci; 2008 Nov; 51(11):973-80. PubMed ID: 18989639
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy against Chlamydophila psittaci by oral immunization based on transgenic rice expressing MOMP in mice.
Zhang XX; Yu H; Wang XH; Li XZ; Zhu YP; Li HX; Luo SJ; Yuan ZG
Vaccine; 2013 Jan; 31(4):698-703. PubMed ID: 23196208
[TBL] [Abstract][Full Text] [Related]
14. Chitosan particle stabilized Pickering emulsion/interleukin-12 adjuvant system for Pgp3 subunit vaccine elicits immune protection against genital chlamydial infection in mice.
Shu M; Zhao L; Shi K; Lei W; Yang Y; Li Z
Front Immunol; 2022; 13():989620. PubMed ID: 36505424
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge.
Zuo Z; Zou Y; Li Q; Guo Y; Zhang T; Wu J; He C; Eko FO
Sci Rep; 2021 May; 11(1):10389. PubMed ID: 34001988
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1.
Xu W; Liu J; Gong W; Chen J; Zhu S; Zhang L
Vaccine; 2011 Mar; 29(15):2672-8. PubMed ID: 21324344
[TBL] [Abstract][Full Text] [Related]
17. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with MIP or Pgp3 induces cross-serovar protection against chlamydial genital tract infection in mice.
Luan X; Peng B; Li Z; Tang L; Chen C; Chen L; Wu H; Sun Z; Lu C
Immunobiology; 2019 Mar; 224(2):223-230. PubMed ID: 30558842
[TBL] [Abstract][Full Text] [Related]
19. Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice.
Jupelli M; Guentzel MN; Meier PA; Zhong G; Murthy AK; Arulanandam BP
J Immunol; 2008 Mar; 180(6):4148-55. PubMed ID: 18322226
[TBL] [Abstract][Full Text] [Related]
20. Expression of Chlamydia muridarum plasmid genes and immunogenicity of pGP3 and pGP4 in different mouse strains.
Mosolygó T; Faludi I; Balogh EP; Szabó ÁM; Karai A; Kerekes F; Virók DP; Endrész V; Burián K
Int J Med Microbiol; 2014 May; 304(3-4):476-83. PubMed ID: 24631212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
